publication date: Jul. 15, 2016
Conversation with The Cancer Letter
Kibbe: Anyone Can Build Search Interface With Open-Source NCI Clinical Trials API
Vice President Joe Biden announced a new NCI application programming interface June 29 that will enable third-party developers to connect their bioinformatics software to NCI’s clinical trials database.
When completed, the API is expected to improve access to the data available from NCI on cancer clinical trials that are supported by the institute.
“One of the virtues of an open API is that anyone in the world is free to build their own cancer clinical trials search interface, and use the clinical trials data from NCI to power it,” Warren Kibbe, NCI deputy acting director and director of the institute’s Center for Biomedical Informatics and Information Technology, said to The Cancer Letter. “The API will allow organizations to provide clinical trials information from NCI in their own clinical trial search tools that are tailored to their specific audiences.”
Kibbe spoke with Matthew Ong, a reporter with The Cancer Letter.
Matthew Ong: What is the initiative called, and can you briefly describe how it works? Is it managed through the National Center for Biotechnology Information?
Warren Kibbe: NCI is developing an open application programming interface. Right now, it doesn’t have a formal name, but a prototype of the API is available at https://clinicaltrialsapi.cancer.gov. It uses the same data source—the NCI Clinical Trials Reporting Program—as the clinical trials search pages on cancer.gov.
One of the virtues of an open API is that anyone in the world is free to build their own cancer clinical trials search interface, and use the clinical trials data from … Continue reading 42-28 Kibbe: Anyone Can Build Search Interface With Open-Source NCI Clinical Trials API
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.